Weed (BUDZ) Cost of Revenue (2010 - 2022)

Weed (BUDZ) recorded quarterly Cost of Revenue of -$2230.0 in Q4 2022, down 200.0% quarter-over-quarter from $2230.0 in Q3 2022.

Weed (BUDZ) Cost of Revenue (2010 - 2022) Analysis & Trends

Weed's Cost of Revenue history runs 3 years deep, the most recent figure standing at -$2230.0 for Q4 2022.

In Q4 2022, Cost of Revenue changed N/A year-over-year to -$2230.0; the TTM figure through Mar 2025 stood at -$2230.0 (changed N/A YoY), while the FY2011 annual figure was $12950.0, down 67.78% from the prior year.
Cost of Revenue was -$2230.0 for Q4 2022 at Weed, down from $2230.0 in the prior quarter.
In the past five years, Cost of Revenue ranged from a high of $2230.0 in Q3 2022 to a low of -$2230.0 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Teva Pharmaceutical Industries	38.77 Bn	35.04 Bn	1.97 Bn	696.00 Mn
2	Zoetis	34.11 Bn	32.16 Bn	1.62 Bn	641.00 Mn
3	United Therapeutics	23.68 Bn	21.53 Bn	648.10 Mn	133.40 Mn
4	Aurora Cannabis	16.48 Bn	16.40 Bn	33.43 Mn	34.44 Mn
5	Neurocrine Biosciences	16.19 Bn	14.88 Bn	800.70 Mn	13.80 Mn
6	Elanco Animal Health	11.44 Bn	11.01 Bn	785.00 Mn	586.00 Mn
7	Alkermes	7.28 Bn	6.77 Bn	-116.06 Mn	155.56 Mn
8	Lantheus Holdings	6.48 Bn	5.98 Bn	230.92 Mn	52.68 Mn
9	Hims & Hers Health	6.35 Bn	5.60 Bn	396.79 Mn	222.00 Mn
10	Weed	-	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	-2,230.00
Dec 31, 2022	-2,230.00
Sep 30, 2022	2,230.00
Sep 30, 2022	2,230.00
Dec 31, 2011	12,950.00
Dec 31, 2011	12,950.00
Dec 31, 2010	40,187.00
Dec 31, 2010	40,187.00
Jun 30, 2010	678.00
Jun 30, 2010	678.00